Last reviewed · How we verify
NCT04983290: W-Domus
Outcomes to the Nutritional Need of Patients With Parkinson's Disease
NA trial testing weancare-domus in Deglutition Disorders in 140 participants. Status unknown.
31 December 2021
Quick facts
| Lead sponsor | Milko Zanini |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 140 |
| Start date | 1 November 2021 |
| Primary completion | 31 December 2021 |
| Estimated completion | 30 May 2022 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- weancare-domus
Conditions studied
- Deglutition Disorders — all drugs for Deglutition Disorders →
- Parkinson Disease — all drugs for Parkinson Disease →
- Nursing — all drugs for Nursing →
- Quality of Life — all drugs for Quality of Life →
Sponsor
Milko Zanini
Who can join
18 and older, any sex, with Deglutition Disorders or Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The intervention involves the identification of 140 patients (70 per group), fed throughout the duration of the study with the two different solutions indicated. The subject will be interviewed by identified and trained personnel in order to collect the information and data required by the study with frequency indicated for the individual evaluation sheets. The subject himself will be provided with all the contact and availability information of the referents of the firm for the purpose of requesting information or reporting events. The subject in the studio will be contacted weekly in order to evaluate the trend by the study referents, according to his availability, and personally interviewed by staff belonging to the research group.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Dietary Interventions in Parkinson's Disease.
van der Berg I, Schootemeijer S, Overbeek K, Bloem BR, et al · · 2024 · cited 18× · PMID 38277304 · DOI 10.3233/jpd-230366
Verify or expand the search:
- PubMed search for NCT04983290
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Deglutition Disorders
Currently open trials in the same condition.
- NCT07267468 — Effectiveness of an mHealth Intervention, Based on Rehabilitation and a Personalised Nutrition Plan, in the Recovery and · NA · recruiting
- NCT06630013 — A New Ultrasound Score for Swallowing Disorders Diagnosis in Difficult-to-wean Tracheostomised Patients · recruiting
- NCT06305949 — Clinical Trial on the Safety and Efficacy of Optimized Transcranial Direct Current Stimulation for the Swallowing Functi · NA · recruiting
- NCT05935618 — Occupational Therapy Rehabilitation for Frail Elders with Dysphagia · NA · recruiting
- NCT04005521 — Randomized Study Regarding Preventive Jaw- and Swallowing Intervention for Patients With Head and Neck Cancer · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04983290 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Milko Zanini
- Last refreshed: 28 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04983290.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing